Evidence map›Paper›PMID 42259562›Full record

ArticleBMJ open2026

Association between hypertension status and severity and tinnitus: a cross-sectional analysis of the Fasa adult cohort study.

Amirhossein Najibi, Sina Bazmi, Mehrnaz Moradi, Zahra Mohammadi, Abdulhakim Al Kamel, Mohammad Hosein Yazdanpanah, Motjaba Farjam

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amirhossein NajibiStudent Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
Sina BazmiNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.ORCID http://orcid.org/0000-0002-2128-0924
Mehrnaz MoradiStudent Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
Zahra MohammadiNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.ORCID http://orcid.org/0009-0006-8075-0427
Abdulhakim Al KamelClinical Research Development Unit, Valiasr Hospital, Fasa University of Medical Sciences, Fasa, Iran.
Mohammad Hosein YazdanpanahLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0003-3645-9430
Motjaba FarjamNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran farjam.phd@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies and meta-analyses suggest an association between hypertension and tinnitus; however, the influence of hypertension severity and control status remains unclear.

objectiveWe aimed to investigate the association between hypertension and tinnitus in detail using a large, population-based dataset from a rural setting.DesignObservational cross-sectional study.SettingSheshdeh, Fasa, Iran.

participantsWe analysed data from 9775 individuals in the general population, aged 35-70 years, excluding those with a history of cancer, pregnancy or medical conditions known to cause tinnitus, such as stroke, seizures or multiple sclerosis. Additionally, although the study design aimed to exclude participants using aminoglycosides because of their significant ototoxic effects, no such users were identified during the study period. PRIMARY AND SECONDARY OUTCOMES: Hypertension was defined as a systolic blood pressure (SBP) of ≥140 mm Hg or a diastolic blood pressure (DBP) of ≥90 mm Hg on at least two separate measurements or as current use of antihypertensive medications following a prior diagnosis. These medications included ACE inhibitors, angiotensin receptor blockers, diuretics, aldosterone antagonists and atenolol. Stage I hypertension was classified as an SBP of 140-159 mm Hg or a DBP of 90-99 mm Hg, while stage II was defined as an SBP of ≥160 mm Hg or a DBP of ≥100 mm Hg. Controlled blood pressure was defined as values below these thresholds. Tinnitus, assessed by a self-reported questionnaire, was defined as a continuous wheezing sound in the ear persisting for more than 1 week.

resultsAmong participants (4446 males, 5309 females; mean age 48.55 (SD 9.53) years), the prevalence of tinnitus and hypertension was 7.4% and 19.3%, respectively. Hypertension was significantly associated with higher odds of tinnitus (adjusted OR=1.34; 95% CI 1.10 to 1.62). Notably, even participants with controlled hypertension had a 27% increased odds (OR=1.27; 95% CI 1.02 to 1.59) compared with normotensive individuals. The odds were highest in those with uncontrolled grade II hypertension (OR=2.08; 95% CI 1.25 to 3.47), demonstrating a dose-response relationship.

conclusionsOur findings suggest a positive association between hypertension and tinnitus, with odds increasing alongside the severity and poor control of hypertension. Importantly, even controlled hypertension was associated with elevated odds, indicating that tinnitus screening may be warranted in all hypertensive patients, regardless of control status. These results underscore the need for heightened clinical awareness and further research into the pathophysiological mechanisms linking vascular health and auditory symptoms.

Indexed as

HypertensionTinnitusAdultAgedAntihypertensive AgentsBlood PressureCross-Sectional StudiesFemaleHumansIranMaleMiddle AgedPrevalenceRisk FactorsSeverity of Illness IndexAntihypertensive Agentscardiovascular diseasesessential hypertensionhearing disordershypertension managementtinnitus

Identifiers

PMID42259562
PMCPMC13250232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.